Biomarkers can be classified according to several criteria. It is common to classify them according to their source (imaging biomarkers, body fluid biomarkers and genetic biomarkers) or their utility (diagnosis, evolution and response to medication) Among the imaging biomarkers in MS the most known is MRI by two methods, gadolinium contrast and T2-hypertense lesions, but also important are PET and OCT. Among the body fluid biomarkers the most knows are oligoclonal bands in CSF but several others are under research. Genetic biomarkers are under study but there is nothing conclusive still. Addressing the classification by its utility we have diagnosis biomarkers, evolution biomarkers and response to medication biomarkers.
Multiple sclerosis biomarkers
Alzheimer's disease biomarkers
Multiple sclerosis functional composite
Charcot–Marie–Tooth disease classifications
Multiple sclerosis drug pipeline
Multiple sclerosis research
Amyotrophic lateral sclerosis research
Biochemistry of Alzheimer's disease